Skip to search formSkip to main contentSkip to account menu

566C80

Known as: 566C80 hydroxynaphthoquinone, hydroxynaphthoquinone 566C80, hydroxynaphthoquinone, 566C80 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Atovaquone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
A proteomic insight into the effects of the immunomodulatory hydroxynaphthoquinone lapachol on activated macrophages.
Review
1994
Review
1994
Toxoplasmosis and human immunodeficiency virus (HIV) disease.
One of the commonest opportunistic infections in patients with the acquired immuno-deficiency syndrome (AIDS), is that caused by… 
1992
1992
Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice.
Toxoplasmosis is a frequent opportunistic infection in patients with AIDS. In these patients the major immune deficiencies are a… 
1948
1948
The effect of artificial blood meals containing the hydroxynaphthoquinone M2279 on the developmental cycle pf Plasmodium gallinaceum in Aedes aegypti.
As a part of a study in this laboratory of the action of hydroxynaphthoquinones on Plasmodium gallinaceum in the vertebrate host… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)